A1C to detect diabetes in healthy adults: when should we recheck?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 20566678.
- Also identified by DOI 10.2337/dc10-0588 and PMC identifier 2928354.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the optimal interval for rechecking A1C levels below the diagnostic threshold of 6.5% for healthy adults. This was a retrospective cohort study. Participants were 16,313 apparently healthy Japanese adults not taking glucose-lowering medications at baseline. Annual A1C measures from 2005 to 2008 at the Center for Preventive Medicine, a community teaching hospital in Japan, estimated cumulative incidence of diabetes. Mean age (+/-SD) of participants was 49.7 +/- 12.3 years, and 53% were male. Mean A1C at baseline was 5.4 +/- 0.5%. At 3 years, for those with A1C at baseline of <5.0%, 5.0-5.4%, 5.5-5.9%, and 6.0-6.4%, cumulative incidence (95% CI) was 0.05% (0.001-0.3), 0.05% (0.01-0.11), 1.2% (0.9-1.6), and 20% (18-23), respectively. In those with an A1C <6.0%, rescreening at intervals shorter than 3 years identifies few individuals (approximately <or=1%) with an A1C >or=6.5%.
Medical subject headings
- Diabetes Mellitus
- Glycated Hemoglobin